Astellas Pharma joined PPMD for a webinar on May 19, 2021 to provide an update on the company’s ASP0367 development program. Research & Clinical Trial Webinars, Webinars Posted on May 21, 2021 FacebookTwitterLinkedinPin ItWhatsApp You may also like 37:26 Webinar: Viltepso, An FDA-Approved Treatment for Patients Amenable to Exon 53 Skipping (March 2023) Posted on March 27, 2023 Research & Clinical Trial Webinars, Webinars 54:44 Webinar: Avidity Biosciences – EXPLORE44 Clinical Trial Investigating AOC 1044 (February 2023) Posted on February 13, 2023 Research & Clinical Trial Webinars, Webinars 1:17:46 Webinar: Capricor Data Update From Ongoing HOPE-2 Open Label Extension Trial (January 2023) Posted on January 31, 2023 Research & Clinical Trial Webinars, Webinars 1:09:29 Connect with the Experts: Pulmonary Management in the Winter Season Posted on December 21, 2022 Care Webinars, Webinars 45:50 Webinar: A Conversation with PTC Therapeutics (December 2022) Posted on December 9, 2022 Research & Clinical Trial Webinars, Webinars 53:21 Webinar: Edgewise Therapeutics – A Novel Approach to Protect Muscle in Duchenne & Becker (October 2022) Posted on October 21, 2022 Research & Clinical Trial Webinars, Webinars 56:16 Connect With the Experts: Genitourinary Health (October 2022) Posted on October 20, 2022 Care Webinars, Webinars 58:15 Webinar: Psychosocial Considerations for Women in Duchenne (September 2022) Posted on October 5, 2022 Care Webinars, Webinars «123456…24»Page 4 of 24